Zonisamide + Placebo

Phase 3Completed

2 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Partial Seizures

Conditions

Partial Seizures

Trial Timeline

Sep 1, 2006 → May 1, 2008

NCT ID

NCT00327717

About Zonisamide + Placebo

Zonisamide + Placebo is a phase 3 stage product being developed by Eisai for Partial Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT00327717. Target conditions include Partial Seizures.

What happened to similar drugs?

18 of 20 similar drugs in Partial Seizures were approved

Approved (18) Terminated (5) Active (2)

✅Perampanel + PlaceboEisaiApproved

✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved

✅PerampanelEisaiApproved

✅Eslicarbazepine acetate + Eslicarbazepine AcetateSumitomo PharmaApproved

✅OxcarbazepineNovartisApproved

✅Hydrocortisone + PlaceboNovo NordiskApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (5)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01765608	Phase 2	Completed	Mar 1, 2010	Jun 1, 2013	Sleep Apnea
NCT00566254	Phase 3	Completed	Dec 1, 2008	Mar 1, 2011	Epilepsy; Paediatric Partial Onset Seizures
NCT00692003	Phase 3	Terminated	Aug 1, 2008	Jan 9, 2009	Epilepsy
NCT00693017	Phase 3	Terminated	Jun 1, 2008	—	Epilepsy
NCT00327717	Phase 3	Completed	Sep 1, 2006	May 1, 2008	Partial Seizures

Competing Products

20 competing products in Partial Seizures

See all competitors

Product	Company	Stage	Hype Score
E2007	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
perampanel + perampanel	Eisai	Phase 1	29
perampanel + perampanel + perampanel + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Approved	35
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
perampanel	Eisai	Phase 2	35
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide	Eisai	Pre-clinical	26
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Phase 3	40
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Adjunctive Zonisamide + Replacement with Zonisamide	Eisai	Approved	43
Fycompa	Eisai	Pre-clinical	26
Fycompa	Eisai	Pre-clinical	26
Rufinamide	Eisai	Phase 3	32
Zonisamide	Eisai	Phase 3	40
Eslicarbazepine Acetate tablets	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26